financial results Nov 11, 2022 Earnings Roundup: T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen Nov 10, 2022 Becton Dickinson Fiscal Q4 Revenues Decline 2 Percent Nov 10, 2022 Cue Health Q3 Revenues Decline 69 Percent Nov 9, 2022 Siemens Healthineers Cutting Dx Instrument Portfolio, Reports Q4 Revenues Rise 16 Percent Premium Nov 9, 2022 Quanterix Posts Large Drop in Reagent Sales as Restructuring Effort Tackles Quality Control Premium Nov 9, 2022 Natera Raises Guidance on Test Volume Growth, Notes Reimbursement Opportunities Premium Nov 9, 2022 Earnings Roundup: OraSure Technologies, LumiraDx, Opko, More Nov 8, 2022 Invitae Q3 Revenues Rise 17 Percent as Company Revises Cash Burn Guidance Nov 8, 2022 In First Quarter With New CEO, NeoGenomics Refines Growth Strategy Premium Nov 8, 2022 PerkinElmer Q3 Revenues Drop 17 Percent, Diagnostics Off 39 Percent Nov 8, 2022 Sophia Genetics Posts 12 Percent Increase in Q3 Revenues Nov 7, 2022 Fulgent Q3 Total Revenues Fall 54 Percent, Non-COVID Revenues Double Nov 7, 2022 Qiagen Reports Double-Digit Q3 Non-COVID Sales Growth, Raises FY22 Guidance Nov 4, 2022 Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations Nov 3, 2022 Guardant Health Sees Promising Q3 Uptake of Shield CRC Screening Test Premium Nov 3, 2022 CareDx Q3 Revenues Grow 5 Percent, Miss Analyst Estimates Nov 3, 2022 Exact Sciences Q3 Revenues Rise 15 Percent Nov 3, 2022 QuidelOrtho Continues to See Supply Chain Impacts; Combined Q3 Revenues up 54 Percent Premium Nov 2, 2022 Veracyte Reports 25 Percent Q3 Revenue Growth, Raises Full-Year Guidance Nov 2, 2022 Castle Biosciences Q3 Revenues up 58 Percent on Strong Melanoma Test Volume Load More Breaking News European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal AnPac Bio to Raise $5M in Private Placement Top Five Articles on 360Dx Last Week: Sherlock Bio's $2M Award; Nostics' POC Testing Plans; and More KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More BTIG Downgrades Oncocyte to Neutral Following News of CEO Departure
